Odyssey Therapeutics Announces $304 Million Upsized IPO and Private Placement

Covington and Wilson Sonsini have advised Odyssey Therapeutics. Cooley has advised the underwriters. Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on autoimmune and inflammatory diseases,…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here